跳至主導覽 跳至搜尋 跳過主要內容

Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer

  • Chun Hui Lee
  • , Jason Chia Hsun Hsieh
  • , Tyler Min Hsien Wu
  • , Ting Shiuan Yeh
  • , Hung Ming Wang
  • , Yung Chan Lin
  • , Jen Shi Chen
  • , Chia Lin Lee
  • , Wen Kuan Huang
  • , Tsung Min Hung
  • , Tzu Tsen Yen
  • , Sheng Chieh Chan
  • , Wen Chi Chou
  • , Feng Che Kuan
  • , Ching Chih Hu
  • , Pei Hung Chang*
  • *此作品的通信作者
  • Chang Gung Memorial Hospital
  • Chang Gung University
  • Ming Chi University of Technology
  • Veterans General Hospital-Taichung Taiwan
  • China Medical University Taichung

研究成果: 期刊稿件 › 文章 › 同儕審查

24 引文 斯高帕斯(Scopus)

摘要

Background: Circulating tumor cells (CTCs) are associated with breast cancer prognosis. Research is limited regarding the role of circulating cancer stem-like cells (cCSCs) considering the treatment response and survival among patients with metastatic breast cancer. Accordingly, we performed this prospective study to clarify the prognostic significance of baseline cCSCs for metastatic breast cancer in terms of first-line chemotherapy. Methods: Between April 2014 and January 2016, we prospectively enrolled 48 patients with stage IV breast invasive ductal carcinoma who underwent first-line chemotherapy. We identified and analyzed CTCs and cCSCs by using a protocol based on negative selection and flow cytometry before chemotherapy. CTCs were identified as EpCAM+Hoechst+CD45- cells and cCSCs as CD133+EpCAM+Hoechst+CD45- cells. cCSCs were expressed as a percentage of CTCs. The associations between CTCs, cCSCs, and the clinicopathological variables that were predictive of the treatment response and survival outcome were analyzed using univariate and multivariate analyses. Results: We identified CTCs in all the enrolled patients, with a median number of 33.9/mL CTCs. CSCs were isolated in 97.9% of the patients; the median percentage of cCSCs was 14.7%. A high baseline level of cCSCs was correlated with an inferior tumor response rate (54.2% vs. 95.8%, p < 0.001), overall survival (OS; median: 27.7 months vs. not reached, p < 0.001), and progression-free survival (PFS; median: 5.7 vs. 18.0 months, p < 0.001). Multivariate analysis revealed that along with other clinical variables, baseline cCSCs remained an independent prognostic factor for OS and PFS. Conclusions: Baseline cCSCs predict the treatment response as well as survival in patients with metastatic breast cancer undergoing first-line chemotherapy. Therefore, the measurement of cCSCs may assist in identifying early cancer treatment response and prognosis.

原文英語
文章編號1167
期刊BMC Cancer
卷19
發行號1
DOIs
出版品狀態已出版 - 02 12 2019

文獻附註

Publisher Copyright:
© 2019 The Author(s).

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer」主題。共同形成了獨特的指紋。

引用此